A medical diagnostic device company with a vision to develop a low cost diagnostic platform for hemostasis monitoring in cardiovascular disease management, Abram Scientific, Inc has developed a first-of-its-kind, disruptive blood coagulation diagnostic platform capable of translating multiple lab-based tests to a cost-effective, hand-held format. With the firm's initial work in the SBIR arena being NSF funded, in January 2021 it was announced that the Army had awarded to firm a medical research grant for the firm to deliver a portable viscoelastic, blood coagulation diagnostic platform for COVID-19 associated Coagulopathy Management. The firm's CoagCare System is a novel diagnostic platform for diagnosis and characterization of coagulation-related disorders, delivering rapid hemostasis information to improve clinical outcomes.
